Eton Pharmaceuticals, Inc. (ETON) Net income 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$4.6MFY2025 · since FY2018: -$12.7M → -$4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.6M | -20.4% |
| FY2024 | -$3.8M | -308.4% |
| FY2023 | -$936,000 | +89.6% |
| FY2022 | -$9.0M | -361.4% |
| FY2021 | -$2.0M | +93.0% |
| FY2020 | -$28.0M | -52.7% |
| FY2019 | -$18.3M | -43.8% |
| FY2018 | -$12.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice